Liraglutide plus upstream risk factors modification advice and consultation clinical trials

Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )

This study looks at whether a weight-loss medicine called Liraglutide can help people with an irregular heartbeat (Atrial Fibrillation or AF) who are overweight. The aim is to see if losing weight before a heart procedure called ablation can improve its success and overall health.